Teratogenic effects of imidacloprid exposure on neurogenesis and neural tube development in early stage chicken embryos
Environmental Toxicology and Pharmacology · 2026-08 · 125 · 105083
DOI: 10.1016/j.etap.2026.105083 ↗Kurz gefasst
Fachartikel in der Zeitschrift Environmental Toxicology and Pharmacology, 2026-08. Verfasst von Abdulkadir Bilir und 6 weiteren Autor:innen. Beteiligte Einrichtung: Afyonkarahisar Health Sciences University, Faculty of Medicine, Department of Anatomy, Afyonkarahisar, Turkey. Electronic address: abdulkadir.bilir@a…. Hauptthemen laut MEDLINE: Neonicotinoids, Nitro Compounds, Neurogenesis, Insecticides. Die Arbeit nennt 55 Literaturangaben.
Abstract (Originalsprache)
Neonicotinoid insecticides, particularly imidacloprid, are widely used worldwide and have raised increasing concerns regarding their potential developmental neurotoxicity. However, data on the effects of imidacloprid exposure during early embryogenesis, especially on neural tube development and neurogenesis, remain limited. This study aimed to investigate the teratogenic effects of imidacloprid on neural tube development and neurogenesis in early embryonic stages using a chicken embryo model. 110 specific pathogen free (SPF) eggs were randomly assigned to a control group (saline) or four imidacloprid groups (0.1, 0.5, 1, and 5mg/kg), and all solutions were administered via sub-blastodermic injection. Embryos were evaluated at 48hours of incubation using morphometric assessments based on Hamburger-Hamilton staging. In addition, immunohistochemical and genetic analyses were performed. Imidacloprid exposure resulted in a dose-dependent increase in neural tube defects and developmental delay. Cysteine-dependent aspartate-directed protease-3 (Caspase-3) and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) positivity significantly increased, while proliferating cell nuclear antigen (PCNA) immunoreactivity decreased, indicating enhanced apoptosis and suppressed cellular proliferation. Gene expression analyses revealed significant dysregulation of neurogenesis- and proliferation-associated pathways, particularly involving fibroblast growth factor (FGF) signaling and cell cycle control. The results highlight the teratogenic potential of imidacloprid and underscore the importance of incorporating developmental neurotoxicity endpoints into pesticide risk assessment frameworks.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Afyonkarahisar Health Sciences University, Faculty of Medicine, Department of Anatomy, Afyonkarahisar, Turkey. Electronic address: abdulkadir.bilir@afsu.edu.tr.
- Afyonkarahisar Health Sciences University, Faculty of Medicine, Department of Anatomy, Afyonkarahisar, Turkey.
- Afyonkarahisar Health Sciences University, Faculty of Medicine, Department of Medical Biology, Afyonkarahisar, Turkey.
- Afyonkarahisar Health Sciences University, Faculty of Medicine, Department of Histology and Embryology, Afyonkarahisar, Turkey.
Zitieren
APA
Bilir, A., Ertekin, T., Atay, E., Soylemez, Z., Aladag, T., Kurt, G. A., & Emirali, M. (2026). Teratogenic effects of imidacloprid exposure on neurogenesis and neural tube development in early stage chicken embryos. Environmental Toxicology and Pharmacology, 125, 105083. https://doi.org/10.1016/j.etap.2026.105083
Vancouver
Bilir A, Ertekin T, Atay E, Soylemez Z, Aladag T, Kurt GA, et al. Teratogenic effects of imidacloprid exposure on neurogenesis and neural tube development in early stage chicken embryos. Environmental Toxicology and Pharmacology. 2026;125:105083. doi:10.1016/j.etap.2026.105083
BibTeX
@article{Bilir2026,
author = {Bilir, Abdulkadir and Ertekin, Tolga and Atay, Emre and Soylemez, Zafer and Aladag, Tugce and Kurt, Gulan Albas and Emirali, Melike},
title = {Teratogenic effects of imidacloprid exposure on neurogenesis and neural tube development in early stage chicken embryos},
journal = {Environmental Toxicology and Pharmacology},
year = {2026},
volume = {125},
pages = {105083},
doi = {10.1016/j.etap.2026.105083}
}
EUVIMED